Atrial Fibrillation Surgery Market worth $1.73 Billion by 2020


Posted May 17, 2016 by mmvaidya01

the global AF surgery product market was worth $791.5 Million in 2014 and is estimated to reach $1.73 Billion by 2020.

 
Browse 18 market data tables and 73 Slides and in-depth TOC on "Atrial Fibrillation Surgery Market”
http://www.marketsandmarkets.com/Market-Reports/atrial-fibrillation-surgery-market-8998731.html
Early buyers will receive 10% customization on this report.

Atrial fibrillation (AF) is the most common type of arrhythmia that causes an irregular and often fast heart rhythm. Over the past two decades, an increasing prevalence of atrial fibrillation cases is seen across the globe. According to American Heart Association, around 33.5 million people were suffering from atrial fibrillation around the world in 2013.

Catheter ablation procedures dominate the total atrial fibrillation procedures performed in 2014 and are expected to be the fastest growing procedure during forecast period of 2015 to 2020. However, over the last 30 years, surgical therapy for patients with atrial fibrillation has undergone significant advancements. The development in the surgical ablation technology and better results of these procedures are driving the overall number of surgical ablation procedures. The number of surgical atrial fibrillation procedures is also expected to grow at a CAGR close to catheter ablation during forecast period of 2015 to 2020.

Speak To Our Research Analysts:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=8998731

About 4.4% people out of diagnosed atrial fibrillation population are treated using ablation technology in the U.S., Europe, and Japan combined. The atrial fibrillation population treated with ablation is expected to grow with a double digit rate in these regions. The increasing prevalence of atrial fibrillation and advancement in the ablation technologies drive the use of ablation products in the treatment of atrial fibrillation.

The European Society of Cardiology guidelines recommend use of surgical and catheter ablation procedures for the treatment of atrial fibrillation, if anti-arrhythmic drug therapy results are inadequate. Further, guidelines recommend using surgical ablation for the treatment of patients failing catheter ablation.

This market is segmented, on the basis of surgical procedures, into catheter ablation and surgical ablation. Catheter ablation procedures hold the maximum share in this market and are expected to grow with the highest CAGR during forecast period of 2015 to 2020.

Read More | Get The Sample Pages:
http://www.marketsandmarkets.com/requestsample.asp?id=8998731

North America and Europe together accounted for more than 85% of the global atrial fibrillation surgical ablation product market in 2014. The preferable use of advanced surgical products attributed to the larger share of these regions in the global atrial fibrillation surgical ablation product market.

The U.S. is in the largest market for atrial fibrillation catheter ablation products and expected to be growing with highest CAGR during 2015-2020. In Europe, Germany is estimated to be the fastest growing country during the forecast period. India and China would serve as the most lucrative markets for atrial fibrillation catheter products as the regulatory policies in these countries are more adaptive and business-friendly.

About MarketsandMarkets:
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Maharashtra, India.
Tel: +1-888-6006-441.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Makarand Vaidya
Country India
Categories Health , Medical , Science
Tags af surgery , af surgery market , atrial fibrillation , atrial fibrillation surgery , atrial fibrillation surgery market
Last Updated May 17, 2016